News
-
-
-
COMMUNIQUÉ DE PRESSE
METAVISIO - Thomson Computing annonce la publication des résultats préliminaires du 1er semestre 2026. La restructuration permet à l'entreprise de renouer avec les bénéfices.
Résultats semestriels positifs pour METAVISIO - THOMSON Computing en 2026, suite à des mesures de réduction des coûts et une augmentation de marges. Perspectives favorables pour le second semestre -
COMMUNIQUÉ DE PRESSE
Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Heidelberg Pharma AG and Huadong Medicine receive NMPA approval for Phase Ib/II clinical trial of HDP-101 combination therapy in China. Evaluation of BCMA-targeting ADC in patients with multiple myeloma -
-
-
-
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Altarea and Praemia group settle dispute with comprehensive agreement, including settlement payment of €10 million. Praemia strengthens equity base with €60 million subscription by Altarea